144 related articles for article (PubMed ID: 35187437)
1. The Optimal Cutoff Value of Neutrophil/Lymphocyte Ratio for Severe Grades of Diabetic Retinopathy.
Ilhan C; Citirik M; Uzel MM; Tekin K
Beyoglu Eye J; 2019; 4(2):76-81. PubMed ID: 35187437
[TBL] [Abstract][Full Text] [Related]
2. Association Between Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) With Diabetic Retinopathy in Type 2 Diabetic Patients.
Dascalu AM; Georgescu A; Costea AC; Tribus L; El Youssoufi A; Serban D; Arsene AL; Stana D; Alexandrescu C; Cristea BM; Tanasescu D; Bobirca A; Serboiu C; Alius C; Bratu DG
Cureus; 2023 Nov; 15(11):e48581. PubMed ID: 38090430
[TBL] [Abstract][Full Text] [Related]
3. The Value of White Cell Inflammatory Biomarkers as Potential Predictors for Diabetic Retinopathy in Type 2 Diabetes Mellitus (T2DM).
Dascalu AM; Serban D; Tanasescu D; Vancea G; Cristea BM; Stana D; Nicolae VA; Serboiu C; Tribus LC; Tudor C; Georgescu A; Tudosie MS; Costea DO; Bratu DG
Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626602
[TBL] [Abstract][Full Text] [Related]
4. The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus.
Zeng J; Chen M; Feng Q; Wan H; Wang J; Yang F; Cao H
Diabetes Metab Syndr Obes; 2022; 15():3617-3626. PubMed ID: 36444389
[TBL] [Abstract][Full Text] [Related]
5. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in patients with type 2 diabetes at different stages of diabetic retinopathy.
Gao Y; Lu RX; Tang Y; Yang XY; Meng H; Zhao CL; Chen YL; Yan F; Cao Q
Int J Ophthalmol; 2024; 17(5):877-882. PubMed ID: 38766329
[TBL] [Abstract][Full Text] [Related]
6. Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy.
Yue S; Zhang J; Wu J; Teng W; Liu L; Chen L
Int J Environ Res Public Health; 2015 Aug; 12(8):10009-19. PubMed ID: 26308022
[TBL] [Abstract][Full Text] [Related]
7. [Association of choroidal thickness with diabetic retinopathy at different stages].
Wang S; Lin S; Zheng Y; Di F; Cao X; Liu C; Yang J
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2584-8. PubMed ID: 26711604
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis.
Yang QH; Zhang Y; Zhang XM; Li XR
Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489
[TBL] [Abstract][Full Text] [Related]
10. Vascular responsiveness in type 2 diabetes mellitus (T2DM).
Blum A; Socea D; Sirchan R
QJM; 2016 Dec; 109(12):791-796. PubMed ID: 27289111
[TBL] [Abstract][Full Text] [Related]
11. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study.
Pidro A; Ahmedbegovic-Pjano M; Grisevic S; Sofic-Drino V; Gabric K; Biscevic A
Mater Sociomed; 2019 Dec; 31(4):290-293. PubMed ID: 32082096
[TBL] [Abstract][Full Text] [Related]
13. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
15. Ocular blood flow velocity determined by color Doppler imaging in diabetic retinopathy.
Gracner T
Ophthalmologica; 2004; 218(4):237-42. PubMed ID: 15258411
[TBL] [Abstract][Full Text] [Related]
16. MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy.
Citirik M; Beyazyildiz E; Simsek M; Beyazyildiz O; Haznedaroglu IC
Eye (Lond); 2015 Mar; 29(3):376-9. PubMed ID: 25523200
[TBL] [Abstract][Full Text] [Related]
17. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
[TBL] [Abstract][Full Text] [Related]
18. EVALUATION OF MULTISPECTRAL IMAGING IN DIAGNOSING DIABETIC RETINOPATHY.
Li L; Zhang P; Liu H; Liu YH; Gao L
Retina; 2019 Sep; 39(9):1701-1709. PubMed ID: 29901495
[TBL] [Abstract][Full Text] [Related]
19. Exploratory study of non-invasive, high-resolution functional macular imaging in subjects with diabetic retinopathy.
Campagnoli TR; Somfai GM; Tian J; DeBuc DC; Smiddy WE
Int J Ophthalmol; 2021; 14(1):57-63. PubMed ID: 33469484
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice.
Moshfeghi A; Garmo V; Sheinson D; Ghanekar A; Abbass I
Clin Ophthalmol; 2020; 14():3651-3659. PubMed ID: 33154625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
